4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-15-081889
Chief Executive Officer bought 535 shares at $1.76 ($941)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-11-23 | Purchase : show line 1 in the form | +535 | $1.76 | $941 | 6,835 | D |
| Open-market purchases · 535 sh · avg $1.76 · $941 | ||||||
Loading xslF345X03/doc4.xml…